Drug Approval | March 09, 2024
Venus Remedies obtains marketing authorizations for essential oncology drugs in Ukraine
These approvals mark significant progress for Venus Remedies in expanding its market presence
These approvals mark significant progress for Venus Remedies in expanding its market presence
BHL will undertake the development and supply of these molecules
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Launch innovative vitamin sublingual sprays
Yesafili, received marketing authorization approval from the European Commission for the European Union
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)